Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
AstraZeneca obesity pill cuts body weight by 10.5% in phase II trial | investingLive — Investinglive
AstraZeneca obesity pill cuts body weight by 10.5% in phase II trial | investingLive
Investinglive
View source article
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
AstraZeneca obesity pill cuts body weight by 10.5% in phase II trial | investingLive — Investinglive